2003•PROGRESS IN BIOCHEMISTRY AND BIOPHYSICSRequires access

Recombinant Adenovirus-mediated VEGF_(121) cDNA Gene Transfer and Expression In vitro

Yue Wang

Open publisher page 0 citations

Abstract

The replication-incompetent adenoviral vector containing the cDNA of VEGF 121 was constructed. After transfection, individual viral plaques were isolated and amplified in HEK293 cells. Confirmed by PCR, both Adeno-X-VEGF 121 and Adeno-X-LacZ were propagated in HEK293 cells and were purified by CsCl density gradient centrifugation. Adenovirus-mediated VEGF 121 gene transfer promotes ECV304 proliferation and formation of capillary-like structures in vitro. The expression of VEGF 121 by adenovirus-infected ECV304 was quantified by enzymelinked immunosorbent assay. Peak VEGF 121 production was achived at 7~10 days after infection. The conditioned media from ECV304 infected with Adeno-X-VEGF 121 markedly enhanced vascular permeability. These data may support that adenovirus-mediated VEGF 121 cDNA gene transfer could provide a useful strategy for efficient delivery of VEGF 121 in the treatment of ischemic diseases.

About this research paper

What this paper is about

The replication-incompetent adenoviral vector containing the cDNA of VEGF 121 was constructed. After transfection, individual viral plaques were isolated and amplified in HEK293 cells. Confirmed by PCR, both Adeno-X-VEGF 121 and Adeno-X-LacZ were propagated in HEK293 cells and were purified by CsCl density gradient centrifugation. Adenovirus-mediated VEGF 121 gene transfer promotes ECV304 proliferation and formation of capillary-like structures in vitro. The expression of VEGF 121 by adenovirus-infected ECV304 was quantified by enzymelinked immunosorbent assay. Peak VEGF 121 production was achived at 7~10 days after infection. The conditioned media from ECV304 infected with Adeno-X-VEGF 121 markedly enhanced vascular permeability. These data may support that adenovirus-mediated VEGF 121 cDNA gene transfer could provide a useful strategy for efficient delivery of VEGF 121 in the treatment of ischemic diseases.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The replication-incompetent adenoviral vector containing the cDNA of VEGF 121 was constructed. After transfection, individual viral plaques were isolated and amplified in HEK293 cells. Confirmed by PCR, both Adeno-X-VEGF 121 and Adeno-X-LacZ were propagated in HEK293 cells and were purified by CsCl density gradient centrifugation. Adenovirus-mediated VEGF 121 gene transfer promotes ECV304 proliferation and formation of capillary-like structures in vitro. The expression of VEGF 121 by adenovirus-infected ECV304 was quantified by enzymelinked immunosorbent assay. Peak VEGF 121 production was achived at 7~10 days after infection. The conditioned media from ECV304 infected with Adeno-X-VEGF 121 markedly enhanced vascular permeability. These data may support that adenovirus-mediated VEGF 121 cDNA gene transfer could provide a useful strategy for efficient delivery of VEGF 121 in the treatment of ischemic diseases.

Key concepts: Complementary DNA, Molecular biology, Transfection, In vitro, HEK 293 cells, Viral vector, Gene delivery, Genetic enhancement

Related papers

Back to paper searchBrowse research topicsOriginal source
Recombinant Adenovirus-mediated VEGF_(121) cDNA Gene Transfer and Expression In vitro — Research Paper | ScholarLens